Holland & Knight Health Dose: July 25, 2023

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • This Week: Legislative Push Before August Recess
  • House Committee Examines Medicare Coverage of Innovative Drugs, Devices
  • House Committee on Energy and Commerce Holds Full Healthcare Markup
  • Senate HELP Committee Advances PAHPA Reauthorization Bill
  • Lawmakers Continue to Push for PEPFAR Reauthorization
  • HHS OIG Releases Report on Medicaid Managed Care Prior Authorization Practices
  • White House Establishes Permanent Pandemic Preparedness Office

Read the full Health Dose »

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More